Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05714033

A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.

Detailed description

Primary Objective: To compare the proportion of patients developing target-obscuring atelectasis when using a lateral decubitus strategy (LADS) vs using a ventilatory strategy to prevent atelectasis (VESPA) during robotic bronchoscopy for posteriorly-located peripheral lung lesions. Secondary Objectives: * To compare the proportion of patients with atelectasis in the target lobe in VESPA vs. LADS during robotic bronchoscopy. * To compare the proportion of patients with atelectasis obscuring 100%, 50% or more, and less than 50% of the target during robotic bronchoscopy using LADS vs. VESPA. * To compare the proportion of patients in whom a biopsy sample was not taken due to atelectasis using LADS vs. VESPA. * To compare the diagnostic yield using LADS vs. VESPA. * To compare the proportion of tool in lesion (TIL) using LADS vs. VESPA. * To compare the diagnostic accuracy (sensitivity and specificity) for malignancy using LADS vs. VESPA. * To compare the proportion of LADS-induced vs. VESPA-induced complications. * To compare the proportion of bronchoscopy-induced complications in LADS vs. VESPA. * To compare the accuracy of 3D-2D image registration using LADS vs. VESPA. * To compare clinical workflow in robotic bronchoscopy with VESPA and LADS strategies to identify potential improvements in workflow.

Conditions

Interventions

TypeNameDescription
PROCEDUREVentilatory Strategy To Prevent AtelectasisGiven
PROCEDURELateral Decubitus Strategy (LADS)Given

Timeline

Start date
2023-02-10
Primary completion
2032-09-14
Completion
2032-09-14
First posted
2023-02-06
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05714033. Inclusion in this directory is not an endorsement.